FDA Vaccine Regulator Joins Big Pharma Amid Controversy
Peter Marks, the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli Lilly as senior vice president of molecule discovery and head of infectious disease. Marks, who held his position at the federal agency for nearly a decade, reportedly clashed with Health and Human Services Secretary Robert F. Kennedy…